http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0294069-A3

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D473-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D473-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D317-18
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C239-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C239-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C67-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D473-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D317-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D317-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12
filingDate 1988-05-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1990-08-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-0294069-A3
titleOfInvention Purine compounds, process for their preparation, intermediates and pharmaceutical compositions
abstract The (S)-isomer of a compound of formula (I), optionally nin admixture with up to 45% of the mixture by weight of nthe corresponding (R)-isomer: n nwherein the OH groups in the chain are optionally in nthe form of O-acyl, phosphate, cyclic acetal or cyclic ncarbonate derivatives thereof; having antiviral nactivity, a process for preparation and use as npharmaceuticals.
priorityDate 1987-05-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0242482-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1061
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411550719
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457490455

Total number of triples: 24.